The estimated Net Worth of Kenneth F Meyers is at least $1.95 millió dollars as of 9 November 2020. Mr. Meyers owns over 4,658 units of Syneos Health Inc stock worth over $1,670,633 and over the last 9 years he sold SYNH stock worth over $0. In addition, he makes $275,000 as Independent Director at Syneos Health Inc.
Kenneth has made over 11 trades of the Syneos Health Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 4,658 units of SYNH stock worth $446,004 on 9 November 2020.
The largest trade he's ever made was exercising 10,330 units of Syneos Health Inc stock on 5 November 2019 worth over $1,071,428. On average, Kenneth trades about 2,157 units every 56 days since 2015. As of 9 November 2020 he still owns at least 38,870 units of Syneos Health Inc stock.
You can see the complete history of Mr. Meyers stock trades at the bottom of the page.
Kenneth F. Meyers serves as Independent Director of the Company. He is an independent director who joined our Board in October 2016, and is the Chair of the Compensation and Management Development Committee and a member of the Nominating and Corporate Governance Committee. Mr. Meyers currently serves as Senior Vice President and Chief Human Resources Officer at Hillrom (NYSE:HRC), a global medical technology company, a position he has held since 2015. He previously held the same role at Hospira, Inc., a manufacturer and distributor of generic injectable pharmaceuticals, biosimilars and medical devices, from 2008 until its acquisition by Pfizer, Inc. in 2015. From 2004 to 2008, Mr. Meyers was a partner with Mercer/Oliver Wyman, a consulting firm specializing in leadership development. He also has served in senior human resources roles for Starbucks Coffee International, The Gymboree Corporation, Walt Disney Imagineering and United Technologies Corporation. Mr. Meyers serves on the board of directors and the Nominating Committee for Elyssa’s Mission, a community-based non-profit organization dedicated to preventing teen suicide. He also is a member of the board of directors and Chair of the Compensation Committee for The Henry P. Kendall Foundation, an organization working to create healthy and sustainable food systems in New England, and a member of the board of directors of The Norfolk Charitable Foundation. Mr. Meyers holds a Bachelor’s degree with dual majors in International Business and Human Resource Management from the Wharton School of the University of Pennsylvania, and an MBA from the Harvard Business School.
As the Independent Director of Syneos Health Inc, the total compensation of Kenneth Meyers at Syneos Health Inc is $275,000. There are 12 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.
Kenneth Meyers is 58, he's been the Independent Director of Syneos Health Inc since 2016. There are 3 older and 18 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
Kenneth's mailing address filed with the SEC is C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE, NC, 27560.
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado és Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
Syneos Health Inc executives and other stock owners filed with the SEC include: